Market closedNon-fractional
SurModics/SRDX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About SurModics
Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.
Ticker
SRDX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Eden Prairie, United States
Employees
376
Website
www.surmodics.com
SurModics Metrics
BasicAdvanced
$593M
Market cap
43.55
P/E ratio
$0.95
EPS
1.18
Beta
-
Dividend rate
Price and volume
Market cap
$593M
Beta
1.18
Financial strength
Current ratio
4.389
Quick ratio
3.329
Long term debt to equity
26.349
Total debt to equity
27.157
Interest coverage (TTM)
5.19%
Management effectiveness
Return on assets (TTM)
6.61%
Return on equity (TTM)
11.92%
Valuation
Price to earnings (TTM)
43.549
Price to revenue (TTM)
4.095
Price to book
4.87
Price to tangible book (TTM)
10.86
Price to free cash flow (TTM)
25.955
Growth
Revenue change (TTM)
38.84%
Earnings per share change (TTM)
-137.08%
3-year revenue growth (CAGR)
10.24%
3-year earnings per share growth (CAGR)
22.27%
What the Analysts think about SurModics
Analyst Ratings
Majority rating from 4 analysts.
SurModics Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q2 24
QoQ growth
Revenue
$32M
4.59%
Net income
$200K
-128.57%
Profit margin
0.62%
-127.07%
SurModics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Actual
$0.52
$0.53
-
$0.07
-
Expected
$0.05
$0.19
-$0.30
-$0.32
-$0.33
Surprise
893.64%
186.49%
-
-121.88%
-
SurModics News
AllArticlesVideos
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. – SRDX
GlobeNewsWire·3 weeks ago
STOCKHOLDER ALERT: The M&A Class Action Firm Investigates Merger of Surmodics, Inc. - SRDX
PRNewsWire·3 weeks ago
Surmodics Awarded Thrombectomy Products Agreement with Premier, Inc.
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for SurModics stock?
SurModics (SRDX) has a market cap of $593M as of July 27, 2024.
What is the P/E ratio for SurModics stock?
The price to earnings (P/E) ratio for SurModics (SRDX) stock is 43.55 as of July 27, 2024.
Does SurModics stock pay dividends?
No, SurModics (SRDX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next SurModics dividend payment date?
SurModics (SRDX) stock does not pay dividends to its shareholders.
What is the beta indicator for SurModics?
SurModics (SRDX) has a beta rating of 1.18. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell SurModics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.